Spastic Paraplegia 15
SPG15

Contact us
 
Return to database




Prevalence (%) of clinical parameters based on data from 1 references describing 38 individuals







Add new symptom/sign to this disease

Select symptom from list or write it in the box
Pubmed id number as a reference Organ system affected
Number of patients in the reference Percent affected patients (Between 0 and 1, eg. 0.1 = 10%)
Please provide your name and contact information as a reference
Name Institute Phone number Email address


List of symptoms



Symptom/sign Organ system Percent affected Pubmed id Added on(yyyy-mm-dd) Edit/add reference
Spasticity nervous 100 % 19805727 2019-12-10
Hyperactive reflexes nervous 100 % 19805727 2019-12-10
Babinski's sign nervous 100 % 19805727 2019-12-10
Mental retardation nervous 79 % 19805727 2019-12-10
Corpus callosum thining nervous 79 % 19805727 2019-12-10
Neuropathy nervous 65 % 19805727 2019-12-10
White matter hyperintensities nervous 52 % 19805727 2019-12-10
Muscle atrophy skeletal 49 % 19805727 2019-12-10
Dysarthria nervous 49 % 19805727 2019-12-10
Cerebral atrophy nervous 44 % 19805727 2019-12-10
Ataxia nervous 37 % 19805727 2019-12-10
Retinitis pigmentosa nervous 33 % 19805727 2019-12-10
Pallesthesia nervous 27 % 19805727 2019-12-10
Cerebellar atrophy nervous 26 % 19805727 2019-12-10
Hearing loss nervous 18 % 19805727 2019-12-10



List of references:


SPG15 is the second most common cause of hereditary spastic paraplegia with thin corpus callosum.
C Goizet, A Boukhris, D Maltete, L Guyant-Maréchal, J Truchetto, E Mundwiller, S Hanein, P Jonveaux, F Roelens, J Loureiro, E Godet, S Forlani, J Melki, M Auer-Grumbach, J C Fernandez, P Martin-Hardy, I Sibon, G Sole, I Orignac, C Mhiri, P Coutinho, A Durr, A Brice, G Stevanin,



Neurology - Oct 2009